Although such a direct relationship between estrogen levels and insulin resistance was not completely confirmed in human subjects, with a possible dose-dependent effect of sex hormones on risk for diabetes having been observed in smaller studies, the overall evidence presented above justifies concern when considering ovarian suppression treatment by GnRH analogues in premenopausal women affected by breast cancer. The gene discussed is GNRH1; the disease is diabetes mellitus.